Ketamine for Suicidal Thoughts: What the Research Shows and Where It Fits

Short answer: If you are in danger right now, call or text 988 (the Suicide & Crisis Lifeline), or call 911 or go to the nearest emergency room, because ketamine is not an emergency treatment and outpatient clinics like ours are not crisis services. Outside of a crisis, research suggests ketamine can reduce suicidal thoughts within hours to days for many people with depression, though the effect can be temporary and works best inside a broader plan of ongoing psychiatric care.

Crisis care comes first

Suicidal thoughts sit on a spectrum. Passive thoughts, such as wishing you would not wake up, are common in depression and deserve real attention. Thoughts that come with intent or a plan are a medical emergency, and the right place for them is 988, 911, or an emergency department, not a scheduled appointment.

The 988 Lifeline is free, confidential, and available around the clock, and you can call on behalf of someone you love.

What the research shows

The most cited evidence is a 2018 meta-analysis in the American Journal of Psychiatry led by Samuel Wilkinson at Yale. Pooling individual data from 167 people with suicidal ideation across 10 controlled trials, it found that a single IV ketamine infusion reduced suicidal thoughts more than comparison treatments, beginning within the first day and lasting up to about a week. The effect was partly independent of improvement in overall depression.

A separate 2018 trial in the same journal, led by Michael Grunebaum at Columbia, found a greater reduction in suicidal thoughts at 24 hours with ketamine than with an active placebo.

The caveats matter. Samples were small, many trials excluded people at the highest risk, follow-up was short, and no study has shown that ketamine prevents suicide.

What the Spravato label says

In 2020, the FDA approved esketamine nasal spray (Spravato) for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior, used alongside an oral antidepressant. The label is careful: it states that Spravato has not been shown to prevent suicide or to reduce suicidal ideation or behavior, and that it does not replace hospitalization when clinically warranted, even if a person improves after a first dose.

Spravato is given only in certified settings with monitoring afterward. Ketamine Uplift now offers Spravato alongside our IV ketamine program, and our complete guide to Spravato explains how the two approaches differ in practice.

Why speed matters

Standard antidepressants often take several weeks to show their full effect, and for someone carrying persistent suicidal thoughts, those weeks can feel very long. Ketamine's appeal is speed. Our guide to how fast ketamine works for depression covers the typical timeline in more detail.

Faster relief does not solve the underlying illness on its own. What it can do, for many patients, is open a window where therapy, medication changes, and a written safety plan have room to take hold.

The limits, plainly

The effect of a single infusion can fade within days to weeks. A series and periodic boosters may extend benefit, but durability varies. Ketamine also carries real side effects, including dissociation, temporary rises in blood pressure, and nausea.

That is why ketamine belongs inside a comprehensive plan, not in place of one: an ongoing psychiatrist or therapist, a safety plan built with a clinician, and people who know what is going on. Ketamine is one tool for treating depression and the thoughts that can come with it, not a standalone answer.

Who outpatient ketamine is and is not for

Outpatient ketamine may be appropriate for adults with depression, including those with passive suicidal thoughts, who are stable enough for outpatient care and connected to ongoing mental health support. It is not appropriate for anyone with active intent, a plan, or rapidly escalating risk. That situation needs emergency or inpatient care first, and treatment decisions can follow once safety is established. Certain medical and psychiatric conditions also rule it out, which our article on who is not a good candidate walks through.

At Ketamine Uplift, Dr. O'Neill's complimentary telehealth evaluation begins with a safety check. If a higher level of care is the right call, we will tell you directly.

This article is for educational purposes only and is not medical advice. Ketamine is a controlled medication administered under medical supervision. Consult a licensed provider about your individual situation.

The bottom line

Research suggests ketamine can quiet suicidal thoughts quickly for many people with depression, and esketamine carries an FDA approval for depressive symptoms in this group. But the effect can be temporary, it has not been shown to prevent suicide, and it works best as one part of ongoing care. If you are in danger now, call or text 988 or call 911. If you are safe and want to talk through whether treatment fits, call us at (310) 280-4440.

Frequently asked questions

Can ketamine help with suicidal thoughts? Research suggests a single IV infusion can reduce suicidal thoughts within a day for many people with depression. It has not been shown to prevent suicide and belongs inside a broader treatment plan.

How fast does ketamine work on suicidal ideation? In controlled studies, reductions often appeared within a day of an infusion. The effect can fade, which is why ongoing psychiatric care matters.

Is Spravato approved for suicidal thoughts? It is FDA approved for depressive symptoms in adults with major depression who have acute suicidal ideation or behavior, alongside an oral antidepressant. Its label states it has not been shown to prevent suicide or reduce suicidal ideation.

Should I go to a ketamine clinic if I am in crisis? No. Outpatient clinics are not crisis services. If you are in danger, call or text 988, call 911, or go to the nearest emergency room.